COVID-19 vaccine: Zydus Cadila gets DGCI nod for phase 3 clinical trials of Pegylated Interferon Alpha-2

Drug firm Zydus Cadila on Friday said it has received the approval from the Drugs Controller General of India (DCGI) to start phase 3 clinical trials with its biological therapy PegiHep in COVID-19 patients.

from IndiaTV India: Google News Feed https://ift.tt/3oket9y

Get Breaking news, Live news, and latest news from India and around the world on INDILIVENEWS.com, which are in the interest of nation and humanity. Like us on Facebook or Follow us on Twitter and Reddit for the latest news blog and live news update